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Introduction: Transthyretin V30M mutation is the most common variant leading to Familial Amyloidotic Polyneuropathy.
In this genetic disorder, Transthyretin accumulates preferentially in the extracellular matrix of peripheral and autonomic
nervous systems leading to cell death and dysfunction. Thus, knowledge regarding important biological systems for
Transthyretin clearance might unravel novel insights into Familial Amyloidotic Polyneuropathy pathophysiology. Herein,
our aim was to evaluate the ability of glial cells from peripheral and autonomic nervous systems in Transthyretin uptake
and degradation. We assessed the role of glial cells in Familial Amyloidotic Polyneuropathy pathogenesis with real-time
polymerase chain reaction, immunohistochemistry, interference RNA and confocal microscopy.
Results: Histological examination revealed that Schwann cells and satellite cells, from an Familial Amyloidotic
Polyneuropathy mouse model, internalize and degrade non-fibrillar Transthyretin. Immunohistochemical studies of
human nerve biopsies from V30M patients and disease controls showed intracellular Transthyretin immunoreactivity in
Schwann cells, corroborating animal data. Additionally, we found Transthyretin expression in colon of this Familial
Amyloidotic Polyneuropathy mouse model, probably being synthesized by satellite cells of the myenteric plexus.
Conclusions: Glial cells from the peripheral and autonomic nervous systems are able to internalize Transthyretin.
Overall, these findings bring to light the closest relationship between Transthyretin burden and clearance from
the nervous system extracellular milieu.
Keywords: Transthyretin, Internalization, Glial cells, Familial amyloidotic polyneuropathy, Peripheral nervous system,
Myenteric plexusIntroduction
Familial Amyloidotic Polyneuropathy (FAP) is a rare but
fulminant and life-threatening neurodegenerative disorder.
Approximately ten thousand patients are affected world-
wide with endemic foci in Portugal, Japan and Sweden [1].
Major neuropathological and neurochemical hallmarks
of this autosomal dominant hereditary disease included
extracellular accumulation of mutated transthyretin (TTR)
aggregates and amyloid fibers, particularly in autonomic and
peripheral nervous systems (ANS and PNS, respectively),
leading to sensorimotor, motor and autonomic neur-
opathy [2].
Transthyretin is a tetramer of identical subunits of 127
amino acid residues each [3]. It is primarily synthesized
by the liver and the choroid plexus of the brain [4,5] and
functions as a protein carrier for thyroxin and retinol* Correspondence: mjsaraiv@ibmc.up.pt
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unless otherwise stated.[6,7]. More than 100 single point TTR mutations have
been discovered, being the exchange of a methionine for
a valine at position 30 (V30M) the most common in FAP
[8]. TTR is mainly produced by the liver as a monomer
that assembles into a tetramer and is efficiently secreted.
This process occurs in most FAP associated mutations,
including carriers of the V30M mutation [9]. Particular
high amyloidogenic mutations, such as the L12P associ-
ated with leptomeningeal amyloidosis, form intracellular
aggregates that are transported into liver lysosomes [10]
and thus these mutants are poorly secreted. Contrarily to
other TTR amyloidoses, L12P cases present liver TTR de-
position [11].
The original amyloid cascade hypothesis proposed that
circulating TTR dissociation into non-native monomers
is a determinating step for misfolding. Thus, monomers
with low conformational stability self-assemble forming
non-fibrillar oligomers, protofibrils and mature amyloid fi-
bers [12,13] that accumulate in the extracellular matrix of
the gastrointestinal tract, skin, heart, kidney and PNS [14].tral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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for TTR deposition. The mechanistic and functional prin-
ciples that underlie this fact are not fully understood.
Hence, converging evidence revealed the importance of
a dynamic balance between formation and clearance of
extracellular deposited TTR [15,16]. Cellular uptake of sol-
uble TTR by hepatocytes, mouse embryonic fibroblasts,
yolk sac cells and sensory neurons, was previously demon-
strated in vitro [17-19]. More recently, intracellular ma-
terial has been observed in fibroblasts and macrophages,
through analysis of skin biopsies from FAP patients and
TTR transgenic mice [20].
Since important target tissues of TTR load belong to
the ANS and PNS, the aim of the present study was to
investigate TTR localization in tissues and cells of these
systems. To perform this work we take advantage of human
nerve biopsies and tissues from a well-established FAP
mouse model, carrying the human TTR V30M gene.
We analyzed TTR expression in the peripheral nerve of
the FAP mouse model using real-time polymerase chain
reaction (qPCR) analysis and determined the subcellular
localization of TTR in satellite cells from mice dorsal root
ganglia (DRG) and Schwann cells (SC). SC from patients
and control subjects were also evaluated, through confocal
double immunofluorescence. An interference RNA (RNAi)
approach was used to study TTR expression/internalization
by satellite cells from the myenteric plexus.Materials and methods
Ethics statement
All mouse protocols followed the European Union Direct-
ive (2010/63/EU) and were previously approved by the In-
stitutional and National General Veterinarian Board ethical
committees. Human tissue biopsy was performed after in-
formed consent and approval from the Ethics Committee
of the Hospital Geral de Santo António (Porto, Portugal),
following the declaration of Helsinki.Human samples
Archival sural nerve biopsy samples obtained from FAP
V30M patients (n = 4) and normal disease control subjects
(n = 4) were previously characterized, after informed con-
sent, for TTR and amyloid deposition, with immunohisto-
chemistry and Congo red staining, respectively. Samples
were kindly provided by the Hospital Geral de Santo
António (Porto, Portugal). FAP samples analyzed in this
study presented TTR amyloid deposition. Disease control
patients were near-relatives of FAP patients who ultim-
ately turned out not to have mutations in TTR. This
material was obtained as part of the clinical diagnosis
and evaluation of polyneuropathy, before the current use
of less invasive methods, as previously described [21].Animals
Six months transgenic mice for human TTR V30M, in the
129/Sv and endogenous Ttr null background, heterozygous
for the heat shock factor-1 (Hsf-1), here designated as Hsf/
V30M [22], were used for the experiments. Although not
presenting amyloid fibers in PNS or ANS, non-fibrillar
TTR material is widespread in the extracellular milieu of
these systems at 6 months of age. Additionally, 6 months-
old Ttr wild-type (WT) and TTR knockout (KO) mice
[23], in a 129/Sv background were used as controls. Ani-
mals were housed in a controlled-temperature room, main-
tained under a 12 h light/dark cycle, with water and food
ad libitum and euthanized with a lethal injection of a
premixed solution containing ketamine (75 mg/kg) and
medetomidine (1 mg/kg).Liver TTR silencing in vivo with RNAi
For TTR-silencing studies, TTR or control siRNA (vehicle)
were formulated into a lipid nanoparticle delivery system
[24]. Five months-old Hsf/V30M mice were injected in
the tail vein with human TTR siRNA (n = 6), at a con-
centration of 1 mg/kg. Untreated age-matched controls
received vehicle intravenously (n = 6). One injection per
week was performed during 4 weeks and animals were
sacrificed 48 h after the last injection. Liver and colon
were divided and collected to 10% formalin and frozen
at −80°C.Messenger RNA (mRNA) isolation, complementary DNA
(cDNA) synthesis and real-time quantitative polymerase
chain reaction (qPCR)
Liver and colon mRNA (n = 6 per group Hsf/V30M; n =
5 WT) was isolated using phenol extraction (Invitrogen,
Carlsbad, CA, USA). Sciatic nerve from Hsf/V30M mice
was dissected free from surrounding tissue (n = 5) and
mRNA extraction performed using RNeasy Mini columns
(Qiagen, Gaithersburg, MD, USA). cDNA was synthesized
with the SuperScript double-stranded cDNA Kit (Invitro-
gen). The quality of extracted RNA was assessed with
Experion RNA StdSens Analysis Kit (Bio-Rad, Hercules,
CA, USA); qPCR was performed in duplicates using iQ
Syber Green Super Mix (Bio-Rad) and reactions were run
on an Bio-Rad iQ5 software.
Primer sequences were designed using Beacon Designer





phosphate dehydrogenase (Gapdh) (Forward: 5’-GCCTTC
CGTGTTCCTACC-3’, Reverse: 5’-AGAGTGGGAGTTG
CTGTTG-3’) and 18S (Forward: 5’-AAATCAGTTATG
GTTCCTTTGGTC-3’, Reverse: 5’-GCTCTAGAATTACC
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mined by the 2^-ΔΔCT method.Immunohistochemistry
Liver and colon from animals subjected to TTR siRNA
treatment and respective controls were excised, post-fixed in
10% formalin, embedded in paraffin and cut longitudinally
at 3 μm. Colon fromWTand KO mice was used as controls
(n= 4). Histoclear (National Diagnostics, Atlanta, GA, USA)
was used to deparaffinate sections that were thereafter hy-
drated in a descent alcohol series. Endogenous peroxidase
activity was inhibited with 3% hydrogen peroxide in metha-
nol and sections were blocked with 10% fetal bovine serum
and 0.5% Triton x-100, in phosphate buffer saline. Primary
antibodies against human TTR (1:600, rabbit polyclonal,
DAKO, Glostrup, Denmark) and mouse Ttr (1:1500, rabbit
polyclonal, Q-Biogen llkirch Cedex, France) were used. After
incubation with secondary antibody (anti-rabbit IgG, 1:200,
Vector, Burlingame, CA, USA), slides were incubated
with avidin-biotin-peroxidase complex (ABC Elite,
Vector) and visualized using 3.3′-diaminobenzidine as
a chromogen.Figure 1 SC express and internalize TTR in the Hsf/V30M FAP mouse
between TTR (green) and Oct-6 (red) in Hsf/V30M nerves, demonstrating TT
DAPI (blue), is shown (merge, n = 4). Scale bar 10 μm. B) Double immunofl
between the 2 proteins in SC of Hsf/V30M mice (arrows). Scale bar 5 μm. C
anti-TTR antibody (green) and a lysosome marker (Lamp1; red). ColocalizatiImmunofluorescent double labeling
For double immunofluorescence analyses, sciatic nerve,
DRG and colon from Hsf/V30M animals were excised
and processed as described above. Human sural nerve biop-
sies were also used. Rabbit polyclonal anti-human TTR
(1:100, DAKO), sheep polyclonal anti-human TTR (1:100,
Abcam, Cambridge, UK), mouse monoclonal anti-heparan
sulfate proteoglycans (1:100, Amsbio, Tokyo, Japan), goat
polyclonal anti-Octamer transcription factor 6 (Oct-6, 1:25,
Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit
polyclonal anti-S100 (1:100, DAKO), rabbit polyclonal anti-
early endosome antigen 1 (EEA1, 1:100, Sigma-Aldrich, St.
Louis, MO, USA) and mouse monoclonal anti-lysosomal-
associated membrane protein 1 (Lamp1, 1:75, Abcam) were
used as primary antibodies. Secondary antibodies included
donkey anti-rabbit Alexa Fluor 488, donkey anti-goat Alexa
Fluor 568, donkey anti-sheep Alexa Fluor 488, goat
anti-rabbit Alexa Fluor 568, goat anti-mouse Alexa Fluor
568 and 488 (1:1,000 Molecular Probes, Oregan, USA).
Slides were mounted with Vectashield containing 4’.6-
diamino-2-phenylindole (DAPI) (Vector) and visualized
in a laser scanning Confocal Microscope Leica TCS SP5
II (Leica Microsystems, Heidelberg, Germany).model. A) Representative picture of double immunofluorescence
R intracellular staining in SC (arrows). Superposition of the labels, with
uorescence of TTR (green) and EEA1 (red) demonstrating colocalization
) Confocal representative image of a sciatic nerve section stained with
on between both markers was noticed in yellow; scale bar 5 μm.
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were detected by merged images with anti-TTR anti-
body and a SC marker (Oct-6). The number of TTR-
immunopositive SC in each group was calculated as an
average of 5 visual fields (447.63 μm × 335.40 μm) per
sample (n = 4 per group) at an original magnification of
20x, in a Axio Imager (Zeiss, Hertfordshire, UK).
Statistical analysis
Two or three groups’ comparison was performed with
Student T-test or One-way ANOVA, respectively. For One-
way ANOVA, Bonferroni was used as the post test. Data
are expressed as mean values ± standard error of the mean
(SEM) and p-values of less than 0.05 were considered to be
significant (p* < 0.05, p** < 0.01 and ***p < 0.001).
Results
Non-fibrillar TTR is produced and degraded by Schwann
cells in the FAP mouse model Hsf/V30M
Expression of TTR by SC of sciatic nerve in a mouse model
carrying the TTR V30M mutation but missing TTR depos-
ition in the PNS and ANS was previously described [25].
Thus, we questioned whether this feature is recapitulated
in an FAP mouse model deficient for the Hsf-1 (Hsf/
V30M). In this model, non-fibrillar TTR deposition isFigure 2 Glial cells from DRG internalize TTR, in a mouse model of FA
marker for glial cells, in DRG of Hsf/V30M mice, showing TTR localized insid
colocalizing with EEA1 in satellite cells from DRG of Hsf/V30M animals. Scal
image demonstrating colocalization between TTR (green) and lysosomes (Lwidespread along the gastrointestinal tract since the
first month of age. Furthermore regarding the nervous
system, TTR deposits are found in the extracellular
matrix of sciatic nerve, DRG and parasympathetic ganglia
approximately at 6 months of age [22]. For this reason,
animals with 6 months-old were chosen for subsequent
analyses.
Using qPCR, TTR expression by the sciatic nerve of
Hsf/V30M mice was found (61.7 units ratio of TTR mRNA
and Gapdh mRNA± 16.2 SEM). With double immuno-
fluorescence between TTR and Oct-6, a SC marker, TTR
intracellular staining in these cells was noticed (Figure 1A,
arrows), suggesting them as the primary source of TTR in
nerve, in accordance with previous results from other FAP
mouse models [25,26].
To localize TTR within SC, additional studies were per-
formed using double immunofluorescence between TTR
and a marker for early endosome antigen 1 (EEA1). Look-
ing for cells previously stained with Oct-6, consecutive
cross-sectional images revealed that indeed SC presented
intracellular punctuate material, visible in higher magnifica-
tion, that colocalize with EEA1 (Figure 1B, arrows). Further
labeling with TTR and Lamp1 demonstrated colocalization
of V30M TTR with lysosomes (Figure 1C), indicating that
SC, might also be important for TTR clearance.P. A) Double immunofluorescence of TTR (green) and S100 (red), a
e satellite cells. Scale bar 20 μm; higher magnification 5 μm. B) TTR
e bar 20 μm; higher magnification 5 μm. C) Representative confocal
amp1; red) in satellite cells from DRG (arrows). Scale bar 8 μm.
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ganglia
Data reported so far indicate that SC, besides being a
source of TTR might also be important for TTR clear-
ance in the sciatic nerve. We next investigated TTR im-
munoreactive glial cells from DRG of Hsf/V30M mice.
In fact, with double immunofluorescence between TTR
and S100, TTR intracellular staining was found in glial cells
of DRG (possible satellite cells; Figure 2A). Since it was pre-
viously shown that TTR is not synthesized by cells of DRG
[27] and in this work we found colocalization of TTR with
EEA1 (Figure 2B), we hypothesized that satellite cells have
an active role in TTR internalization. Moreover, we found
TTR signal partially colocalized with lysosomes (Figure 2C);Figure 3 Intracellular TTR in SC of human nerve biopsies. A) Represen
colocalization (yellow and orange in merged panel) between TTR (red) and he
15 μm. B) Representative images from double immunofluorescence between
individuals and FAP patients, demonstrating TTR intracellular staining in SC. Su
bar 4 μm. C) Low magnification images from longitudinal sections of human
bar 40 μm. Chart represents quantification of TTR positive SC, related to totaltherefore we can conclude that these cells participate in
TTR clearance in this animal model.
Intracellular TTR in human Schwann cells
It was previously found that TTR fibril extracts contain
heparan sulfate proteoglycans [28,29]. Thus, we started
by characterizing TTR deposits on sural nerve biopsies
from FAP patients regarding this glycosaminoglycan.
As illustrated in merged panel of Figure 3A, heparan
sulfate colocalized with TTR deposits, demonstrating that
heparan sulfate is present in TTR deposits as co-localized
molecules. Following the previous results with the FAP
mouse model, we wondered if intracellular TTR could also
be observed in nerves from FAP patients. To address thistative photomicrographs obtained with confocal microscopy showing
paran sulfate (green) in sural nerve biopsies from FAP patients. Scale bar
TTR (green) and Oct-6 (red) in sural nerve biopsies from disease control
perposition of the labels, with DAPI (blue), is shown (merge, n = 4). Scale
sural nerves showing colocalization between TTR and Oct-6 (arrows); scale
SC in nerve sections. Results are presented as means ± SEM (p* < 0.05).
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dividuals (disease free) as controls. In disease control
individuals, the majority of SC were negative for WT
TTR intracellular staining; surprisingly, few positive cells
presented WT TTR immunoreactive punctuate material
(Figure 3B, top panel, and 3C), suggesting that SC might
have an important role for uptake and degradation of WT
TTR reaching the nerve though the blood stream. In FAP
carriers, some SC had generalized V30M TTR intracellu-
lar staining (Figure 3B, bottom panel, and 3C) and the per-
centage of TTR positive SC was significantly higher than
for disease control patients (Figure 3C). TTR colocaliza-
tion with EEA1 was observed in both cases (Figure 4A,
arrows), corroborating the notion that punctuate intra-
cellular material arise from TTR internalization and not
from cell synthesis. Colocalization between TTR and lyso-
somes was scarce (Figure 4B, arrow), most likely related to
sample storage and processing.
Intracellular TTR in satellite cells from the myenteric plexus
In FAP disease, ANS is severely affected by TTR depos-
ition ultimately leading to bladder dysfunction, diarrhea,
malabsorption and motility disturbances [14]. Thus, we
questioned whether satellite cells from the myenteric plexus
may also be able to internalize TTR in FAP. By histo-
logical analysis of Hsf/V30M mice colon, non-fibrillar TTRFigure 4 TTR is internalized by human SC. A) Double immunofluorescenc
the 2 proteins in SC of FAP patients and normal control individuals (arrow
colocalization between TTR (green) and lysosomes (red). Scale bar 3 μm.immunostaining was found in Auerbach plexus (myenteric
plexus) especially inside smaller cells surrounding the
nerve cell bodies (compatible with satellite cells), in
contrast with WT and TTR KO animals that were nega-
tive for TTR (Figure 5A). Following these results, we
performed double immunofluorescence between TTR and
S100 in colon sections of Hsf/V30M animals. Colocaliza-
tion between the two proteins was observed (Figure 5B).
Since the TTR staining present in these cells partially
colocalized with EEA1 (Figure 5C, arrows) and Lamp1
(Figure 5D, arrows), it is reasonable to suggest that sat-
ellite cells have an important role in non-fibrillar TTR
uptake and internalization. However, we could not dis-
card the possibility of TTR synthesis by these cells of
myenteric plexus, especially when TTR production in
colon was already previously suggested [30]. To address
this question we treated 5 months-old Hsf/V30M mice
with TTR siRNA, to inhibit TTR deposition in the gastro-
intestinal tract. With this treatment we were able to si-
lence 92% TTR expression by the liver (Figure 6A and B),
avoiding TTR circulation in plasma and burden in tissues,
as previously described [31]. Nevertheless, TTR immu-
nostaining in satellite cells from myenteric plexus was
equally observed in animals treated with TTR siRNA or
controls (vehicle treated mice) (Figure 6C). By qPCR
we found TTR expression in colon of Hsf/V30M mice,e of TTR (green) and EEA1 (red) showing colocalization spots between
s). Scale bar 4 μm. B) Confocal representative image showing scarce
Figure 5 TTR is internalized by satellite cells from the myenteric plexus. A) TTR immunohistochemical staining on colon myenteric plexus
from WT, TTR KO and Hsf/V30M animals. Scale bar 20 μm. B) Double immunofluorescence between TTR (green) and S100 (red), a satellite cell
marker, showing TTR inside these cells. Scale bar 14 μm; higher magnification 5 μm. C) Representative confocal image of myenteric plexus section
showing a satellite cell with intracellular TTR staining (green) colocalizing with EEA1 (red) (arrows). Scale bar 4 μm. D) Confocal microscopy image with
anti-TTR antibody (green) and lysosome marker (Lamp1; red). Nuclei stained blue with DAPI. Arrows indicate colocalization of TTR with lysosomes. Scale
bar 5 μm.
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and vehicle treated mice (Figure 6D). Additionally, Ttr
expression in colon from WT mice was considerably
lower than in Hsf/V30M mice (Figure 6D). This, together
with the fact that no TTR reactivity was found in satellite
cells from myenteric plexus in WT mice, suggests that
FAP colonic myenteric plexus might be able to synthesize
and clear TTR.
Discussion
FAP is a peculiar form of neuropathy with clinical symp-
toms generally occurring in the second or third decade
of life. However, a late-onset form of disease has also
been described, affecting individuals over 50 years of age
and characterized by low penetrance rate and different
pathological presentations [32]. Sensory impairment, wast-
ing and weakness results from neuronal and axonal lossconsequent to obliteration/dysfunction of small vessels
supplying the nerve tissue, nerve fiber compression by
TTR deposits or toxic effects of amyloid precursors
[32,33]. Additionally, motor sensory type is often found in
FAP, characterized by muscle atrophy with distal predom-
inance and decreased motor conduction velocity [34].
In peripheral nerve, TTR deposits are predominantly
found in the endoneurium, in close contact with SC and
collagen fibrils [2]. Thus, an impairment of axon-SC inter-
action due to SC dysfunction might contribute to axonopa-
thy. Similarly, in nervous ganglia, TTR deposition occurs
in the stroma in close association to satellite cells [35-37].
Satellite cells covering sensory neurons are similar to the
SC of peripheral nerve as they are both derived from the
neural crest of the embryo during development [38]. They
are known as glial supporting cells of the nervous sys-
tem and have important roles on mechanical support to
Figure 6 TTR is expressed by colon of the Hsf/V30M FAP mouse model. A) Photomicrographs illustrating TTR staining in liver of Hsf/V30M
mice, treated with TTR siRNA or vehicle; scale bar 50 μm. B) Histogram represents TTR mRNA levels in liver of Hsf/V30M mice treated with TTR
siRNA as compared with control animals receiving only vehicle. Data was normalized using 18S as the housekeeping gene (p*** < 0.001). C) Histological
images of colonic myenteric plexus from Hsf/V30M mice treated with TTR siRNA as compared with vehicle treated animals. Scale bar 20 μm. D) Histogram
denoting TTR mRNA expression in colon from Hsf/V30M mice treated with vehicle or siRNA and Ttr mRNA from WT animals. Data was normalized using
18S as the housekeeping gene (p** < 0.01).
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ris [39]. TTR expression by glial cells of sensory neurons
was previously suggested [40]. However, this hypothesis
was later disputed and the results were attributed to TTR
contamination by the meninges [27]. Recently, TTR gene
expression by SC of peripheral nerve was reported [25].
Accordingly, in the present study, we also observed TTR
expression in the peripheral nerve of Hsf/V30M mice,
corroborating the previous data.
Glial cells regulate neurons microenvironment and ap-
pear to be actively engaged in the control of extracellular
matrix composition [39]. Thus, several studies indicate
the ability of these cells in the uptake of different sub-
stances [41-45]. Since TTR non-fibrillar deposits are found
in the extracellular matrix in close association with glial
cells, we decided to investigate whether these cells in sen-
sory neurons and peripheral nerve might be important for
TTR uptake in vivo. In fact we found immunoreactive
TTR in satellite and SC, both in the Hsf/V30M transgenic
model and in tissues from FAP patients. Occasionally, the
observed intracellular TTR presented a punctate-like pat-
tern, compatible with its presence within vesicles. Once inthe cell, endocytic vesicles are rapidly targeted to the early
endosomes. Thus, despite the existence of numerous in-
ternalization routes, early endosomes are a focal point
of the endocytic pathway [46,47]. EEA1 is a widely used
marker for early endosomes due to its colocalization
with the transferrin receptor [48]. In this work, TTR colo-
calization with EEA1 and a lysosome marker (Lamp1) in
glial cells of peripheral nerve and sensory ganglia indicate
internalization and consequent vesicular transport of TTR
through early endosomes for degradation.
In Alzheimer's disease, Aβ internalization by glia has
been observed in vitro and in vivo [43,49] suggesting an
important role for these cells in Alzheimer pathology.
Nevertheless, exposure of glial cells to Aβ aggregates could
have detrimental consequences with upregulation of in-
flammatory mediators and nitric oxide, resulting in glia and
neuron cell death [50].
Another striking feature of FAP is severe autonomic
nervous dysfunction, affecting particularly the gastrointes-
tinal tract [14,32]. Initial gastrointestinal symptoms
are severe constipation alternating with periods of diar-
rhea, nausea and vomiting [51]. Evidence suggests that
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clinical pattern of FAP [52]. For instance, in Japanese
FAP patients no significant destruction of the enteric
nervous system is observed [53] while Portuguese FAP
patients present infiltration of amyloid material in the
space between two adjacent ganglia, accompanied by
different degrees of neuronal loss [54]. However, the
mechanisms leading to neuron cell death remain poorly
understood. Some factors that have been associated
with the pathogenesis of gastrointestinal dysfunction are a
depletion of neuroendocrine cells, such as serotonin, som-
atostatin or PYY immunoreactive cells [55], accumulation
of advanced glycation end products [56], loss of interstitial
cells of Cajal [57] and amyloid deposition in sympathetic
ganglia [58]. Although amyloid deposits have not been
found in the myenteric plexus of Hsf/V30M FAP mouse
model, this was the first animal model presenting non-
fibrillar TTR deposition in the autonomic nervous system
of the GI tract [22]. Therefore, we next investigated
whether satellite cells were able to internalize TTR,
also in this system. TTR colocalization with EEA1 and
lysosomes indicated that endocytic trafficking path-
ways are activated in satellite cells from the myenteric
plexus of Hsf/V30M mice. Importantly, this is the first
study showing TTR synthesis by the enteric tissue, in
this FAP mouse model. Therefore, it is reasonable to
suggest that satellite cells may also be synthesizing
mutated TTR which in turn might contribute for the
non-fibrillar TTR deposition. It would be interesting
to confirm these results in biopsy colon specimens from
FAP patients, however such specimens are very difficult to
obtain since the conditions of these patients not often calls
for colonoscopy.
Overall, the present study brings to light new insights
into the FAP pathophysiology. Besides TTR endocytosis
by fibroblasts demonstrated both in vitro and in vivo [20],
TTR internalization in vivo by glial cells of peripheral
nerve, sensory ganglia and myenteric plexus was here
demonstrated. However, whether TTR uptake by these
cells is neuroprotective or neurotoxic leading to glial
and neuronal cell death with autonomic dysfunction needs
further investigation. Furthermore, additional studies are
needed to clarify the molecular mechanisms and signaling
platforms involved in these particular systems.
Conclusions
The results presented in the current study confirm pre-
vious findings that TTR is expressed on peripheral nerve
and colon, possibly by glial cells. SC and satellite cells
from sciatic nerve, DRG and myenteric plexus are able
to internalize and degrade TTR in the Hsf/V30M mouse
model, contributing for TTR extracellular clearance. Add-
itionally, TTR colocalization with EEA1 was found in SC
from human patients, suggesting a dual role for these cellsin FAP. Therefore, an imbalance of this system might trig-
ger or accelerate TTR aggregates deposition in target
tissues. These novel data regarding the physiopathology
of FAP might open new windows of action in the design
of new therapeutic targets.
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